Synta Pharma (SNTA) Reports Q3 Loss of $0.13
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Loss from operations: -14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss from operations: -14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Synta Pharma (NASDAQ: SNTA) reported Q3 EPS of ($0.13), versus ($0.19) reported last year.
For earnings history and earnings-related data on Synta Pharma (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
